Patient-reported outcomes from CANTABRICO: Durvalumab plus platinum-etoposide in first-line treatment of extensive stage small cell lung cancer
Por:
Casado M, Aperribay E, Campelo M, Blanco M, Tain P, Piqueras M, Vega A, Mateos L, Rodriguez J, Calderon V, Majem M, Hernandez A, de la Rosa C, Cabellos R, Sureda B, Baret M, Martos J, Dominguez M, Paz-Ares L
Publicada:
1 mar 2025
Resumen:
|